Anzeige
Mehr »
Sonntag, 22.06.2025 - Börsentäglich über 12.000 News
500 % Kursplus seit Januar. 462 g/t Goldgehalte. Mrd.-Investoren an Bord. Dieser finnische Junior wird heiß!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
366 Leser
Artikel bewerten:
(2)

EDAN Instruments, Inc.: EDAN Highlights Commitment to Global Health at GHF 2025 Satellite Symposium, a Side Event of the World Health Assembly

GENEVA, May 26, 2025 /PRNewswire/ -- Edan Instruments, Inc. (300206.SZ), a leading global medical device company, participated in the Geneva Health Forum (GHF) 2025 Satellite Symposium, held as a side event of the World Health Assembly (WHA). Titled "China's Medical Technology Innovation and Its Implementation for Global Health," the event took place on May 20 in Geneva and was co-organized by Tsinghua University and the Université de Genève. It brought together innovators, policymakers, and development partners to explore how Chinese medical technology is advancing equitable healthcare, particularly in low- and middle-income countries (LMICs).

Panelists at the Satellite Symposium on China's Medical Technology Innovation and Its Implementation for Global Health, held during a World Health Assembly side event in Geneva, May 2025. From left to right: Min Yang, Senior Program Officer, Gates Foundation (Facilitator); Mitoha Ondo'o Ayekaba, Ministry of Health and Social Welfare, Equatorial Guinea; Ira Ovesen, Deputy Representative, UNFPA China; Ye Xu, Senior Health Advisor, Asian Development Bank; and Xicheng Xie, Co-Founder, Edan Instruments, Inc.

Representing EDAN, Co-Founder Mr. Xicheng Xie delivered a keynote sharing the company's experience in delivering accessible innovation to underserved communities. "Real innovation isn't just about cutting-edge technology - it's about bringing the right solutions to the people who need them the most," said Mr. Xie, reflecting on the company's three-decade journey and the evolving meaning of innovation.

In that spirit, Mr. Xie highlighted EDAN's efforts to develop medical technologies that are accessible, practical, and impactful in real-world settings. He shared detailed of an ongoing initiative using EDAN's Nano Series handheld diagnostic ultrasound system to support basic prenatal care in resource-limited environments. The project focuses on equipping primary healthcare workers with tools for early screening and timely referral for at-risk pregnancies. He also noted other impactful technologies, including palm-sized fetal dopplers, EDAN's IQ intelligent algorithm, and its smart ECG web platform - each designed to bridge infrastructure gaps and reduce reliance on scarce medical personnel.

With a long-standing presence across both high-end and resource-limited markets, EDAN has built a truly global footprint - from Europe to Africa. To strengthen local engagement and ensure more responsive service, it has established 22 subsidiaries worldwide. This localized support, combined with a commitment to frontline feedback, drives continuous product improvement and meaningful impact.

EDAN is also actively involved in a range of meaningful projects across LMICs, working alongside NGOs, public health agencies, and development partners. These include maternal health and women's care initiatives in South Africa, portable diagnostic deployments in West Africa, and ultrasound screening programs in Latin America. Each year, nearly 1,000 ultrasound devices are deployed globally through NGO-led programs. These partnerships not only expand access to essential care but also help build local capacity through training and support.

"At EDAN, we believe in bringing innovation and value together to improve the human condition," Xie concluded. "That mission is at the core of everything we do - from product design to global partnerships."

As EDAN celebrates its 30th anniversary in 2025, the company remains steadfast in its mission to deliver innovation that matters - especially for those who need it most.

About Edan Instruments, Inc.
EDAN is dedicated to improving the human condition around the world by delivering value-driven, innovative, and high-quality medical products and services, pioneering a comprehensive line of medical solutions that address a broad range of healthcare practices including Patient Monitoring, Diagnostic ECG, OB/GYN, Ultrasound Imaging,Point-of-Care Testing, In-Vitro Diagnostics, and Animal Care.


Photo - https://mma.prnewswire.com/media/2695614/2_1M.jpg
Logo - https://mma.prnewswire.com/media/2068833/5335181/EDAN_Logo_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/edan-highlights-commitment-to-global-health-at-ghf-2025-satellite-symposium-a-side-event-of-the-world-health-assembly-302464994.html

© 2025 PR Newswire
Zeitenwende! 3 Uranaktien vor der Neubewertung
Ende Mai leitete US-Präsident Donald Trump mit der Unterzeichnung mehrerer Dekrete eine weitreichende Wende in der amerikanischen Energiepolitik ein. Im Fokus: der beschleunigte Ausbau der Kernenergie.

Mit einem umfassenden Maßnahmenpaket sollen Genehmigungsprozesse reformiert, kleinere Reaktoren gefördert und der Anteil von Atomstrom in den USA massiv gesteigert werden. Auslöser ist der explodierende Energiebedarf durch KI-Rechenzentren, der eine stabile, CO₂-arme Grundlastversorgung zwingend notwendig macht.

In unserem kostenlosen Spezialreport erfahren Sie, welche 3 Unternehmen jetzt im Zentrum dieser energiepolitischen Neuausrichtung stehen, und wer vom kommenden Boom der Nuklearindustrie besonders profitieren könnte.

Holen Sie sich den neuesten Report! Verpassen Sie nicht, welche Aktien besonders von der Energiewende in den USA profitieren dürften, und laden Sie sich das Gratis-PDF jetzt kostenlos herunter.

Dieses exklusive Angebot gilt aber nur für kurze Zeit! Daher jetzt downloaden!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.